These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 8844494
1. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality. Libert C, Van Molle W, Brouckaert P, Fiers W. J Inflamm; ; 46(3):139-43. PubMed ID: 8844494 [Abstract] [Full Text] [Related]
2. Augmentation of tumor metastasis by platelet-activating factor. Im SY, Ko HM, Kim JW, Lee HK, Ha TY, Lee HB, Oh SJ, Bai S, Chung KC, Lee YB, Kang HS, Chun SB. Cancer Res; 1996 Jun 01; 56(11):2662-5. PubMed ID: 8653713 [Abstract] [Full Text] [Related]
3. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist. Rabinovici R, Yue TL, Farhat M, Smith EF, Esser KM, Slivjak M, Feuerstein G. J Pharmacol Exp Ther; 1990 Oct 01; 255(1):256-63. PubMed ID: 2213560 [Abstract] [Full Text] [Related]
4. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Tsunoda H, Sakuma Y, Harada K, Muramoto K, Katayama S, Horie T, Shimomura N, Clark R, Miyazawa S, Okano K. Arzneimittelforschung; 1990 Nov 01; 40(11):1201-5. PubMed ID: 2085331 [Abstract] [Full Text] [Related]
5. Detection, characterisation and purification of a murine liver factor capable of desensitising towards the lethal activity of tumour necrosis factor. Wielockx B, Hochepied T, Staelens J, Van Molle W, Brouckaert P, Libert C. Cytokine; 2001 Jul 21; 15(2):59-65. PubMed ID: 11500080 [Abstract] [Full Text] [Related]
6. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. Montrucchio G, Lupia E, de Martino A, Battaglia E, Arese M, Tizzani A, Bussolino F, Camussi G. Am J Pathol; 1997 Aug 21; 151(2):557-63. PubMed ID: 9250168 [Abstract] [Full Text] [Related]
7. Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality. Libert C, Takahashi N, Cauwels A, Brouckaert P, Bluethmann H, Fiers W. Eur J Immunol; 1994 Sep 21; 24(9):2237-42. PubMed ID: 7522168 [Abstract] [Full Text] [Related]
8. Effect of platelet activating factor antagonist WEB 2086 on the production of TNF from murine peritoneal macrophages. Ju DW, Zheng QY, Wang HB, Wang XF, Fang J. Yao Xue Xue Bao; 1993 Sep 21; 28(10):721-7. PubMed ID: 8009983 [Abstract] [Full Text] [Related]
9. Differential response of a(2)-macroglobulin-deficient mice in models of lethal TNF-induced inflammation. Hochepied T, Ameloot P, Brouckaert P, Van Leuven F, Libert C. Eur Cytokine Netw; 2000 Dec 21; 11(4):597-601. PubMed ID: 11125302 [Abstract] [Full Text] [Related]
10. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist. Herbert JM, Fraisse L, Bachy A, Valette G, Savi P, Laplace MC, Lassalle J, Roche B, Lale A, Keane PE. J Lipid Mediat; 1993 Aug 21; 8(1):31-51. PubMed ID: 8257776 [Abstract] [Full Text] [Related]
11. Antiinflammatory and antiallodynic actions of the lignan niranthin isolated from Phyllanthus amarus. Evidence for interaction with platelet activating factor receptor. Kassuya CA, Silvestre A, Menezes-de-Lima O, Marotta DM, Rehder VL, Calixto JB. Eur J Pharmacol; 2006 Sep 28; 546(1-3):182-8. PubMed ID: 16925995 [Abstract] [Full Text] [Related]
12. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor. Chang SW. J Lab Clin Med; 1994 Jan 28; 123(1):65-72. PubMed ID: 8288963 [Abstract] [Full Text] [Related]
13. alpha1-Antitrypsin inhibits the lethal response to TNF in mice. Libert C, Van Molle W, Brouckaert P, Fiers W. J Immunol; 1996 Dec 01; 157(11):5126-9. PubMed ID: 8943423 [Abstract] [Full Text] [Related]
14. Effect of a new and specific PAF-antagonist, WEB 2086, on PAF and endotoxin/tumor necrosis factor induced changes in mortality and intestinal transit velocity. Heuer H. Prog Clin Biol Res; 1989 Dec 01; 308():919-24. PubMed ID: 2780739 [No Abstract] [Full Text] [Related]
15. Alpha 1-acid glycoprotein and alpha 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. Van Molle W, Libert C, Fiers W, Brouckaert P. J Immunol; 1997 Oct 01; 159(7):3555-64. PubMed ID: 9317155 [Abstract] [Full Text] [Related]
16. Acute phase proteins as protective factors against the toxicity of tumor necrosis factor. Libert C. Verh K Acad Geneeskd Belg; 1997 Oct 01; 59(6):515-23. PubMed ID: 9543821 [Abstract] [Full Text] [Related]
17. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice. Sun XM, Hsueh W. J Immunol; 1991 Jul 15; 147(2):509-14. PubMed ID: 2071893 [Abstract] [Full Text] [Related]
18. Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis: role of nuclear factor-kappaB. Nagaki M, Naiki T, Brenner DA, Osawa Y, Imose M, Hayashi H, Banno Y, Nakashima S, Moriwaki H. Hepatology; 2000 Dec 15; 32(6):1272-9. PubMed ID: 11093734 [Abstract] [Full Text] [Related]
19. Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice. Everaerdt B, Brouckaert P, Fiers W. J Immunol; 1994 May 15; 152(10):5041-9. PubMed ID: 8176222 [Abstract] [Full Text] [Related]
20. Y-24180, an antagonist of platelet-activating factor, suppresses interleukin 5 production in cultured murine th(2)cells and human peripheral blood mononuclear cells. Kusuhara H, Yamaguchi S, Matsuyuki H, Sugahara K, Komatsu H, Terasawa M. Cytokine; 2000 Jul 15; 12(7):1120-3. PubMed ID: 10880261 [Abstract] [Full Text] [Related] Page: [Next] [New Search]